newsfilter
← Latest News
PR Newswire·

Lipocine Announces FDA Labeling Changes for Testosterone Products

Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective...